Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Sci Rep ; 10(1): 8713, 2020 05 26.
Article in English | MEDLINE | ID: mdl-32457385

ABSTRACT

Natural tolerance in hexaploid bread wheat (Triticum aestivum L.) to synthetic auxin herbicides is primarily due to rapid metabolic detoxification, but genes encoding these herbicide-detoxifying enzymes have yet to be identified. Herbicide safeners are commonly applied in wheat to achieve herbicide tolerance by inducing the expression and activity of herbicide-detoxifying enzymes. While safeners have been utilized for decades, knowledge of mechanisms that induce gene expression is limited. Our objective was to identify wheat chromosomes possessing genes that endow natural or safener-induced tolerance to halauxifen-methyl (HM), a postemergence (POST) wheat-selective synthetic auxin herbicide, using alien substitution (the S genome of Aegilops searsii) and aneuploid lines. Two POST rates of HM were applied to seedlings with 1-2 leaves (Zadoks stages 11-12), and the highest HM rate was also applied with the safener cloquintocet-mexyl (CM). Wheat chromosomes possessing genes associated only with natural HM tolerance were identified because Ae. searsii is HM-sensitive but CM-responsive. Lines with substitutions for 5A and 5B displayed sensitivity to HM, and experiments with nullisomic-tetrasomic (NT) lines further indicated major genes associated with HM tolerance are present on 5A and 5B chromosomes. However, the genes on 5A appear to play a larger role because lines lacking 5A chromosomes displayed more sensitivity than lines lacking 5B. Overall, these results can be utilized to guide future transcriptome analyses to identify candidate genes that confer HM tolerance in wheat.


Subject(s)
Chromosomes, Plant/genetics , Drug Tolerance , Quantitative Trait Loci , Triticum/growth & development , Chromosome Mapping , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Plant/drug effects , Herbicides/adverse effects , Herbicides/chemistry , Indoleacetic Acids/adverse effects , Indoleacetic Acids/chemistry , Plant Proteins/genetics , Polyploidy , Quantitative Trait Loci/drug effects , Quinolines/adverse effects , Triticum/adverse effects , Triticum/genetics
2.
Sci Rep ; 10(1): 4580, 2020 03 12.
Article in English | MEDLINE | ID: mdl-32165659

ABSTRACT

Aluminium (Al) toxicity is the single most important contributing factor constraining crop productivity in acidic soils. Hydroponics based screening of three rice genotypes, a tolerant (ARR09, AR), a susceptible (IR 1552, IR) and an acid soil adapted landrace (Theruvii, TH) revealed that AR accumulates less Al and shows minimum decrease in shoot and root biomass under Al toxicity conditions when compared with IR. Transcriptome data generated on roots (grown in presence or absence of Al) led to identification of ~1500 transcripts per genotype with percentage annotation ranging from 21.94% (AR) to 29.94% (TH). A total of 511, 804 and 912 DEGs were identified in genotypes AR, IR and TH, respectively. IR showed upregulation of transcripts involved in exergonic processes. AR appears to conserve energy by downregulating key genes of glycolysis pathway and maintaining transcript levels of key exergonic step enzymes under Al stress. The tolerance in AR appears to be as a result of novel mechanism as none of the reported Al toxicity genes or QTLs overlap with significant DEGs. Components of signal transduction and regulatory machinery like transcripts encoding zinc finger protein, calcieurin binding protein and cell wall associated transcripts are among the highly upregulated DEGs in AR, suggesting increased and better signal transduction in response to Al stress in tolerant rice. Sequencing of NRAT1 and glycine-rich protein A3 revealed distinct haplotype for indica type AR. The newly identified components of Al tolerance will help in designing molecular breeding tools to enhance rice productivity in acidic soils.


Subject(s)
Aluminum/toxicity , Gene Expression Profiling/methods , Oryza/growth & development , Quantitative Trait Loci/drug effects , Soil/chemistry , Acids/chemistry , Energy Metabolism/drug effects , Gene Expression Regulation, Plant/drug effects , Gene Regulatory Networks/drug effects , Genotype , Hydroponics , Oryza/drug effects , Oryza/genetics , Plant Proteins/genetics , Plant Roots/drug effects , Plant Roots/genetics , Plant Roots/growth & development
3.
Toxicol Sci ; 172(2): 265-278, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31501888

ABSTRACT

Idelalisib is a phosphatidylinositol 3-kinase inhibitor highly selective for the delta isoform that has shown good efficacy in treating chronic lymphocytic leukemia and follicular lymphoma. In clinical trials, however, idelalisib was associated with rare, but potentially serious liver and lung toxicities. In this study, we used the Collaborative Cross (CC) mouse population to identify genetic factors associated with the drug response that may inform risk management strategies for idelalisib in humans. Eight male mice (4 matched pairs) from 50 CC lines were treated once daily for 14 days by oral gavage with either vehicle or idelalisib at a dose selected to achieve clinically relevant peak plasma concentrations (150 mg/kg/day). The drug was well tolerated across all CC lines, and there were no observations of overt liver injury. Differences across CC lines were seen in drug concentration in plasma samples collected at the approximate Tmax on study Days 1, 7, and 14. There were also small but statistically significant treatment-induced alterations in plasma total bile acids and microRNA-122, and these may indicate early hepatocellular stress required for immune-mediated hepatotoxicity in humans. Idelalisib treatment further induced significant elevations in the total cell count of terminal bronchoalveolar lavage fluid, which may be analogous to pneumonitis observed in the clinic. Genetic mapping identified loci associated with interim plasma idelalisib concentration and the other 3 treatment-related endpoints. Thirteen priority candidate quantitative trait genes identified in CC mice may now guide interrogation of risk factors for adverse drug responses associated with idelalisib in humans.


Subject(s)
Antineoplastic Agents/toxicity , Chemical and Drug Induced Liver Injury/genetics , Lung Injury/genetics , Phosphatidylinositol 3-Kinase/toxicity , Protein Kinase Inhibitors/toxicity , Quantitative Trait Loci/drug effects , Animals , Antineoplastic Agents/blood , Biomarkers/blood , Bronchoalveolar Lavage Fluid/cytology , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/etiology , Chromosome Mapping , Dose-Response Relationship, Drug , Liver Function Tests , Lung Injury/blood , Lung Injury/chemically induced , Mice, Inbred Strains , MicroRNAs/blood , Oxidative Stress , Phosphatidylinositol 3-Kinase/blood , Polymorphism, Single Nucleotide , Protein Kinase Inhibitors/blood , Purines , Quinazolinones , Risk Factors , Species Specificity , Toxicogenetics
4.
Insect Biochem Mol Biol ; 110: 19-33, 2019 07.
Article in English | MEDLINE | ID: mdl-31022513

ABSTRACT

Arthropod herbivores cause dramatic crop losses, and frequent pesticide use has led to widespread resistance in numerous species. One such species, the two-spotted spider mite, Tetranychus urticae, is an extreme generalist herbivore and a major worldwide crop pest with a history of rapidly developing resistance to acaricides. Mitochondrial Electron Transport Inhibitors of complex I (METI-Is) have been used extensively in the last 25 years to control T. urticae around the globe, and widespread resistance to each has been documented. METI-I resistance mechanisms in T. urticae are likely complex, as increased metabolism by cytochrome P450 monooxygenases as well as a target-site mutation have been linked with resistance. To identify loci underlying resistance to the METI-I acaricides fenpyroximate, pyridaben and tebufenpyrad without prior hypotheses, we crossed a highly METI-I-resistant strain of T. urticae to a susceptible one, propagated many replicated populations over multiple generations with and without selection by each compound, and performed bulked segregant analysis genetic mapping. Our results showed that while the known H92R target-site mutation was associated with resistance to each compound, a genomic region that included cytochrome P450-reductase (CPR) was associated with resistance to pyridaben and tebufenpyrad. Within CPR, a single nonsynonymous variant distinguished the resistant strain from the sensitive one. Furthermore, a genomic region linked with tebufenpyrad resistance harbored a non-canonical member of the nuclear hormone receptor 96 (NHR96) gene family. This NHR96 gene does not encode a DNA-binding domain (DBD), an uncommon feature in arthropods, and belongs to an expanded family of 47 NHR96 proteins lacking DBDs in T. urticae. Our findings suggest that although cross-resistance to METI-Is involves known detoxification pathways, structural differences in METI-I acaricides have also resulted in resistance mechanisms that are compound-specific.


Subject(s)
Acaricides/pharmacology , Drug Resistance/genetics , Quantitative Trait Loci/genetics , Tetranychidae/genetics , Animals , Chromosome Mapping , Female , Quantitative Trait Loci/drug effects , Selection, Genetic , Tetranychidae/drug effects
5.
Mol Genet Genomics ; 294(4): 861-873, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30904950

ABSTRACT

Culex pipiens pallens is an important vector that transmits Bancroftian filariasis, Japanese encephalitis and other diseases that pose a serious threat to human health. Extensive and improper use of insecticides has caused insecticide resistance in mosquitoes, which has become an important obstacle to the control of mosquito-borne diseases. It is crucial to investigate the underlying mechanism of insecticide resistance. The aims of this study were to identify genes involved in insecticide resistance based on the resistance phenotype, gene expression profile and single-nucleotide polymorphisms (SNPs) and to screen for major genes controlling insecticide resistance. Using a combination of SNP and transcriptome data, gene expression quantitative trait loci (eQTLs) were studied in deltamethrin-resistant mosquitoes. The most differentially expressed pathway in the resistant group was identified, and a regulatory network was built using these SNPs and the differentially expressed genes (DEGs) in this pathway. The major candidate genes involved in the control of insecticide resistance were analyzed by qPCR, siRNA microinjection and CDC bottle bioassays. A total of 85 DEGs that encoded putative detoxification enzymes (including 61 P450s) were identified in this pathway. The resistance regulatory network was built using SNPs, and these metabolic genes, and a major gene, CYP9AL1, were identified. The functional role of CYP9AL1 in insecticide resistance was confirmed by siRNA microinjection and CDC bottle bioassays. Using the eQTL approach, we identified important genes in pyrethroid resistance that may aid in understanding the mechanism underlying insecticide resistance and in targeting new measures for resistance monitoring and management.


Subject(s)
Culex/genetics , Gene Regulatory Networks/drug effects , Insecticide Resistance , Polymorphism, Single Nucleotide , Animals , Culex/drug effects , Female , Gene Expression Profiling/methods , Gene Expression Regulation/drug effects , Insect Proteins/genetics , Pyrethrins/pharmacology , Quantitative Trait Loci/drug effects , Sequence Analysis, RNA
6.
Genetics ; 210(4): 1509-1525, 2018 12.
Article in English | MEDLINE | ID: mdl-30341085

ABSTRACT

Phenotypic complexity is caused by the contributions of environmental factors and multiple genetic loci, interacting or acting independently. Studies of yeast and Arabidopsis often find that the majority of natural variation across phenotypes is attributable to independent additive quantitative trait loci (QTL). Detected loci in these organisms explain most of the estimated heritable variation. By contrast, many heritable components underlying phenotypic variation in metazoan models remain undetected. Before the relative impacts of additive and interactive variance components on metazoan phenotypic variation can be dissected, high replication and precise phenotypic measurements are required to obtain sufficient statistical power to detect loci contributing to this missing heritability. Here, we used a panel of 296 recombinant inbred advanced intercross lines of Caenorhabditis elegans and a high-throughput fitness assay to detect loci underlying responses to 16 different toxins, including heavy metals, chemotherapeutic drugs, pesticides, and neuropharmaceuticals. Using linkage mapping, we identified 82 QTL that underlie variation in responses to these toxins, and predicted the relative contributions of additive loci and genetic interactions across various growth parameters. Additionally, we identified three genomic regions that impact responses to multiple classes of toxins. These QTL hotspots could represent common factors impacting toxin responses. We went further to generate near-isogenic lines and chromosome substitution strains, and then experimentally validated these QTL hotspots, implicating additive and interactive loci that underlie toxin-response variation.


Subject(s)
Metals, Heavy/toxicity , Neurotoxins/toxicity , Pesticides/toxicity , Quantitative Trait Loci/genetics , Alleles , Animals , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/genetics , Chromosome Mapping , Epistasis, Genetic/drug effects , Genomics , Quantitative Trait Loci/drug effects
7.
Int J Mol Sci ; 19(10)2018 Oct 12.
Article in English | MEDLINE | ID: mdl-30322020

ABSTRACT

The red color of apples (Malus domestica) is an attractive trait for consumers. The green skinned "Granny Smith" cultivar develops red pigmentation after bagging treatment. DNA methylation plays an important role in various developmental processes in plants. To explore the possible functions of DNA methylation in the pigmentation of bagged "Granny Smith" apples, we first analyzed the anthocyanin content of fruit skin following treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-dC). The results revealed an increase in anthocyanin content in bagged fruits following 5-aza-dC treatment, while no anthocyanins were detected in unbagged fruits. In addition, 8482 differentially expressed genes between 5-aza-dC-treated and control groups were identified in bagged fruits by RNA sequencing, including genes encoding transcription factors, enzymes related to anthocyanin accumulation, and methylases. Changes in the expression of these genes may be responsible for 5-aza-dC-induced red pigmentation in bagged fruits of "Granny Smith". The findings provide novel evidence for the involvement of DNA methylation in the red pigmentation of non-red-skinned apples.


Subject(s)
Anthocyanins/biosynthesis , Decitabine/pharmacology , Gene Expression Profiling/methods , Malus/genetics , Plant Proteins/genetics , Biosynthetic Pathways/drug effects , DNA Methylation/drug effects , Gene Expression Regulation, Plant/drug effects , Malus/drug effects , Quantitative Trait Loci/drug effects , Sequence Analysis, RNA , Up-Regulation
8.
Sci Rep ; 8(1): 3434, 2018 02 21.
Article in English | MEDLINE | ID: mdl-29467471

ABSTRACT

Genome-wide association studies (GWAS) have identified over two hundred chromosomal loci that modulate risk of coronary artery disease (CAD). The genes affected by variants at these loci are largely unknown and an untapped resource to improve our understanding of CAD pathophysiology and identify potential therapeutic targets. Here, we prioritized 68 genes as the most likely causal genes at genome-wide significant loci identified by GWAS of CAD and examined their regulatory roles in 286 metabolic and vascular tissue gene-protein sub-networks ("modules"). The modules and genes within were scored for CAD druggability potential. The scoring enriched for targets of cardiometabolic drugs currently in clinical use and in-depth analysis of the top-scoring modules validated established and revealed novel target tissues, biological processes, and druggable targets. This study provides an unprecedented resource of tissue-defined gene-protein interactions directly affected by genetic variance in CAD risk loci.


Subject(s)
Coronary Artery Disease/genetics , Gene Regulatory Networks , Coronary Artery Disease/drug therapy , Drug Discovery , Gene Regulatory Networks/drug effects , Genetic Predisposition to Disease , Genome-Wide Association Study , Humans , Linkage Disequilibrium , Molecular Targeted Therapy , Polymorphism, Single Nucleotide/drug effects , Quantitative Trait Loci/drug effects
9.
Pharmacogenomics J ; 18(5): 665-677, 2018 09.
Article in English | MEDLINE | ID: mdl-29298996

ABSTRACT

Variable responsiveness to zileuton, a leukotriene antagonist used to treat asthma, may be due in part to genetic variation. While individual SNPs were previously associated with zileuton-related lung function changes, specific quantitative trait loci (QTLs) and biological pathways that may contribute have not been identified. In this study, we investigated the hypothesis that genetic variation within biological pathways is associated with zileuton response. We performed an integrative QTL mapping and pathway enrichment study to investigate data from a GWAS of zileuton response, in addition to mRNA expression profiles and leukotriene production data from lymphoblastoid cell lines (LCLs) (derived from asthmatics) that were treated with zileuton or ethanol (control). We identified 1060 QTLs jointly associated with zileuton-related differential LTB4 production in LCLs and lung function change in patients taking zileuton, of which eight QTLs were also significantly associated with persistent LTB4 production in LCLs following zileuton treatment (i.e., 'poor' responders). Four nominally significant trans-eQTLs were predicted to regulate three candidate genes (SELL, MTF2, and GAL), the expression of which was significantly reduced in LCLs following zileuton treatment. Gene and pathway enrichment analyses of QTL associations identified multiple genes and pathways, predominantly related to phosphatidyl inositol signaling via PI3K. We validated the PI3K pathway activation status in a subset of LCLs demonstrating variable zileuton-related LTB4 production, and show that in contrast to LCLs that responded to zileuton, the PI3K pathway was activated in poor responder LCLs. Collectively, these findings demonstrate a role for the PIK3 pathway and its targets as important determinants of differential responsiveness to zileuton.


Subject(s)
Asthma/drug therapy , Asthma/genetics , Hydroxyurea/analogs & derivatives , Phosphatidylinositol 3-Kinases/genetics , Signal Transduction/drug effects , Signal Transduction/genetics , Cell Line , Humans , Hydroxyurea/therapeutic use , Leukotrienes/genetics , Polymorphism, Single Nucleotide/genetics , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , RNA, Messenger/genetics
10.
Sci Rep ; 7(1): 8095, 2017 08 14.
Article in English | MEDLINE | ID: mdl-28808238

ABSTRACT

Seed priming is a commercially used technique for improving seed performance including germination. However, the treatment sometimes reduces seed longevity as a side effect, limiting the storable period or longevity of the seeds. To overcome this problem, molecular mechanisms involved in the loss of seed longevity during priming were analyzed using natural variations of Arabidopsis thaliana. We found that the Est-1 accession retained longevity for longer after priming compared to the reference accession Col-0. QTL analysis using 279 recombinant inbred lines (RILs) derived from the Est-1 × Col-0 detected three QTL regions associated with the loss of seed longevity during priming. Bulked transcriptome analysis (RNA-Seq with bulked RIL populations) revealed that genes related to brassinosteroid (BR) biosynthesis/signaling and cell wall modification were highly expressed in primed seeds with shorter longevity. After priming, BR-deficient mutants cyp85a1/a2 and det2 showed significantly longer longevity than the wild type (WT). Moreover, tetrazolium staining indicated that mutant seed coats were less permeable after priming than those of WT. We suggest that the loss of seed longevity in primed seed is due to increased seed coat permeability, which is positively regulated, at least partly, via BR signaling.


Subject(s)
Arabidopsis/drug effects , Brassinosteroids/pharmacology , RNA, Plant/genetics , Seeds/drug effects , Arabidopsis/genetics , Cell Wall/drug effects , Cell Wall/genetics , Gene Expression Profiling/methods , Gene Expression Regulation, Plant/drug effects , Gene Expression Regulation, Plant/genetics , Germination/drug effects , Germination/genetics , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , Seeds/genetics , Transcriptome/drug effects , Transcriptome/genetics
11.
Alcohol Clin Exp Res ; 41(5): 929-938, 2017 May.
Article in English | MEDLINE | ID: mdl-28273335

ABSTRACT

BACKGROUND: A functional polymorphism within the µ-opioid receptor (OPRM1) gene, rs1799971 (A118G), previously has been associated with measures of alcohol use and sensitivity to its effects, but findings have been inconclusive. A recent study suggested that a second nearby variant within OPRM1, rs3778150, is robustly associated with heroin dependence and fully explained a smaller observed association with rs1799971. Given evidence that the rs3778150-C allele is associated with decreased OPRM1 expression levels in the human brain, the current study sought to test the hypothesis that rs3778150 represents a causal variant within OPRM1 that increases risk for a variety of alcohol use phenotypes. METHODS: Participants with genotype and phenotype data from a larger experimental study (N = 152) were assessed on measures of subjective response to alcohol and alcohol use. Measures included (i) the Self-Rating of the Effects of Alcohol and the Alcohol Sensitivity Questionnaire, (ii) the Biphasic Alcohol Effects Scale (BAES) and ratings of subjective intoxication, and (iii) average number of drinks per week in the past month. RESULTS: Compared to rs3778150-T homozygous individuals, carriers of the rs3778150-C allele exhibited significantly lower retrospective self-report levels of alcohol sensitivity. Carriers of the rs3778150-C allele also exhibited lower levels of BAES alcohol-related stimulation during an alcohol challenge and reported higher levels of drinking in the last 30 days. With the exception of lower levels of BAES alcohol-related sedation, the rs1799971 variant did not show consistent significant association with any of the alcohol phenotypes in the presence of rs3778150. CONCLUSIONS: Results suggest that rs3778150 may be causally related to alcohol use phenotypes, and could potentially account for previously observed associations of rs1799971 with substance use phenotypes. Future studies may investigate potential causal relations among genetic variants in OPRM1, subjective response to alcohol, and drinking phenotypes to further delineate the effects of rs3778150.


Subject(s)
Alcohol Drinking/genetics , Alcoholic Intoxication/genetics , Ethanol/administration & dosage , Genetic Association Studies/methods , Quantitative Trait Loci/genetics , Receptors, Opioid, mu/genetics , Adult , Alcohol Drinking/psychology , Alcoholic Intoxication/psychology , Female , Humans , Male , Quantitative Trait Loci/drug effects , Retrospective Studies , Self Report , Young Adult
12.
Genome Res ; 26(12): 1627-1638, 2016 12.
Article in English | MEDLINE | ID: mdl-27934696

ABSTRACT

Gene-by-environment (GxE) interactions determine common disease risk factors and biomedically relevant complex traits. However, quantifying how the environment modulates genetic effects on human quantitative phenotypes presents unique challenges. Environmental covariates are complex and difficult to measure and control at the organismal level, as found in GWAS and epidemiological studies. An alternative approach focuses on the cellular environment using in vitro treatments as a proxy for the organismal environment. These cellular environments simplify the organism-level environmental exposures to provide a tractable influence on subcellular phenotypes, such as gene expression. Expression quantitative trait loci (eQTL) mapping studies identified GxE interactions in response to drug treatment and pathogen exposure. However, eQTL mapping approaches are infeasible for large-scale analysis of multiple cellular environments. Recently, allele-specific expression (ASE) analysis emerged as a powerful tool to identify GxE interactions in gene expression patterns by exploiting naturally occurring environmental exposures. Here we characterized genetic effects on the transcriptional response to 50 treatments in five cell types. We discovered 1455 genes with ASE (FDR < 10%) and 215 genes with GxE interactions. We demonstrated a major role for GxE interactions in complex traits. Genes with a transcriptional response to environmental perturbations showed sevenfold higher odds of being found in GWAS. Additionally, 105 genes that indicated GxE interactions (49%) were identified by GWAS as associated with complex traits. Examples include GIPR-caffeine interaction and obesity and include LAMP3-selenium interaction and Parkinson disease. Our results demonstrate that comprehensive catalogs of GxE interactions are indispensable to thoroughly annotate genes and bridge epidemiological and genome-wide association studies.


Subject(s)
Gene Expression Profiling/methods , Genome-Wide Association Study/methods , Quantitative Trait Loci/drug effects , Alleles , Caffeine/pharmacology , Cell Line , Gene Expression Regulation/drug effects , Gene-Environment Interaction , Human Umbilical Vein Endothelial Cells , Humans , Melanocytes/cytology , Melanocytes/drug effects , Selenium/pharmacology , Tunicamycin/pharmacology
13.
Psychopharmacology (Berl) ; 233(4): 701-14, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26581503

ABSTRACT

RATIONALE: Cocaine addiction is a major public health problem with a substantial genetic basis for which the biological mechanisms remain largely unknown. Systems genetics is a powerful method for discovering novel mechanisms underlying complex traits, and intravenous drug self-administration (IVSA) is the gold standard for assessing volitional drug use in preclinical studies. We have integrated these approaches to identify novel genes and networks underlying cocaine use in mice. METHODS: Mice from 39 BXD strains acquired cocaine IVSA (0.56 mg/kg/infusion). Mice from 29 BXD strains completed a full dose-response curve (0.032-1.8 mg/kg/infusion). We identified independent genetic correlations between cocaine IVSA and measures of environmental exploration and cocaine sensitization. We identified genome-wide significant quantitative trait loci (QTL) on chromosomes 7 and 11 associated with shifts in the dose-response curve and on chromosome 16 associated with sessions to acquire cocaine IVSA. Using publicly available gene expression data from the nucleus accumbens, midbrain, and prefrontal cortex of drug-naïve mice, we identified Aplp1 and Cyfip2 as positional candidates underlying the behavioral QTL on chromosomes 7 and 11, respectively. A genome-wide significant trans-eQTL linking Fam53b (a GWAS candidate for human cocaine dependence) on chromosome 7 to the cocaine IVSA behavioral QTL on chromosome 11 was identified in the midbrain; Fam53b and Cyfip2 were co-expressed genome-wide significantly in the midbrain. This finding indicates that cocaine IVSA studies using mice can identify genes involved in human cocaine use. CONCLUSIONS: These data provide novel candidate genes underlying cocaine IVSA in mice and suggest mechanisms driving human cocaine use.


Subject(s)
Cocaine-Related Disorders/genetics , Cocaine/administration & dosage , Genetic Association Studies/methods , Administration, Intravenous , Animals , Cocaine-Related Disorders/psychology , Dose-Response Relationship, Drug , Female , Male , Mesencephalon/drug effects , Mesencephalon/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nucleus Accumbens/drug effects , Nucleus Accumbens/physiology , Prefrontal Cortex/drug effects , Prefrontal Cortex/physiology , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , Self Administration , Systems Biology/methods
14.
Hum Mol Genet ; 23(18): 5017-24, 2014 Sep 15.
Article in English | MEDLINE | ID: mdl-24770851

ABSTRACT

Nearly one-half of asthmatic patients do not respond to the most commonly prescribed controller therapy, inhaled corticosteroids (ICS). We conducted an expression quantitative trait loci (eQTL) analysis using >300 expression microarrays (from 117 lymphoblastoid cell lines) in corticosteroid (dexamethasone) treated and untreated cells derived from asthmatic subjects in the Childhood Asthma Management Program (CAMP) clinical trial. We then tested the associations of eQTL with longitudinal change in airway responsiveness to methacholine (LnPC20) on ICS. We identified 2484 cis-eQTL affecting 767 genes following dexamethasone treatment. A significant over-representation of lnPC20-associated cis-eQTL [190 single-nucleotide polymorphisms (SNPs)] among differentially expressed genes (odds ratio = 1.76, 95% confidence interval: 1.35-2.29) was noted in CAMP Caucasians. Forty-six of these 190 clinical associations were replicated in CAMP African Americans, including seven SNPs near six genes meeting criteria for genome-wide significance (P < 2 × 10(-7)). Notably, the majority of genome-wide findings would not have been uncovered via analysis of untreated samples. These results indicate that identifying eQTL after relevant environmental perturbation enables identification of true pharmacogenetic variants.


Subject(s)
Asthma/genetics , Dexamethasone/pharmacology , Gene Expression Regulation/drug effects , Methacholine Chloride/pharmacology , Quantitative Trait Loci , Black or African American/genetics , Asthma/drug therapy , Cell Line , Child , Child, Preschool , Humans , Polymorphism, Single Nucleotide , Quantitative Trait Loci/drug effects , White People/genetics
15.
PLoS Genet ; 10(4): e1004192, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24699359

ABSTRACT

Annotating and interpreting the results of genome-wide association studies (GWAS) remains challenging. Assigning function to genetic variants as expression quantitative trait loci is an expanding and useful approach, but focuses exclusively on mRNA rather than protein levels. Many variants remain without annotation. To address this problem, we measured the steady state abundance of 441 human signaling and transcription factor proteins from 68 Yoruba HapMap lymphoblastoid cell lines to identify novel relationships between inter-individual protein levels, genetic variants, and sensitivity to chemotherapeutic agents. Proteins were measured using micro-western and reverse phase protein arrays from three independent cell line thaws to permit mixed effect modeling of protein biological replicates. We observed enrichment of protein quantitative trait loci (pQTLs) for cellular sensitivity to two commonly used chemotherapeutics: cisplatin and paclitaxel. We functionally validated the target protein of a genome-wide significant trans-pQTL for its relevance in paclitaxel-induced apoptosis. GWAS overlap results of drug-induced apoptosis and cytotoxicity for paclitaxel and cisplatin revealed unique SNPs associated with the pharmacologic traits (at p<0.001). Interestingly, GWAS SNPs from various regions of the genome implicated the same target protein (p<0.0001) that correlated with drug induced cytotoxicity or apoptosis (p ≤ 0.05). Two genes were functionally validated for association with drug response using siRNA: SMC1A with cisplatin response and ZNF569 with paclitaxel response. This work allows pharmacogenomic discovery to progress from the transcriptome to the proteome and offers potential for identification of new therapeutic targets. This approach, linking targeted proteomic data to variation in pharmacologic response, can be generalized to other studies evaluating genotype-phenotype relationships and provide insight into chemotherapeutic mechanisms.


Subject(s)
Antineoplastic Agents/pharmacology , Polymorphism, Single Nucleotide/genetics , Proteins/genetics , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , Apoptosis/drug effects , Apoptosis/genetics , Cell Line, Tumor , Cisplatin/pharmacology , Genome, Human/genetics , Genome-Wide Association Study/methods , Genotype , HapMap Project , Humans , Paclitaxel/pharmacology , Pharmacogenetics/methods , Phenotype , Proteome/genetics , Proteomics/methods , Transcription Factors , Transcriptome/genetics
16.
PLoS One ; 8(4): e61654, 2013.
Article in English | MEDLINE | ID: mdl-23637875

ABSTRACT

Glucocorticoids (GCs) are key mediators of stress response and are widely used as pharmacological agents to treat immune diseases, such as asthma and inflammatory bowel disease, and certain types of cancer. GCs act mainly by activating the GC receptor (GR), which interacts with other transcription factors to regulate gene expression. Here, we combined different functional genomics approaches to gain molecular insights into the mechanisms of action of GC. By profiling the transcriptional response to GC over time in 4 Yoruba (YRI) and 4 Tuscans (TSI) lymphoblastoid cell lines (LCLs), we suggest that the transcriptional response to GC is variable not only in time, but also in direction (positive or negative) depending on the presence of specific interacting transcription factors. Accordingly, when we performed ChIP-seq for GR and NF-κB in two YRI LCLs treated with GC or with vehicle control, we observed that features of GR binding sites differ for up- and down-regulated genes. Finally, we show that eQTLs that affect expression patterns only in the presence of GC are 1.9-fold more likely to occur in GR binding sites, compared to eQTLs that affect expression only in its absence. Our results indicate that genetic variation at GR and interacting transcription factors binding sites influences variability in gene expression, and attest to the power of combining different functional genomic approaches.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Glucocorticoids/pharmacology , NF-kappa B/metabolism , Receptors, Glucocorticoid/metabolism , Transcriptome/drug effects , Cell Line , Gene Expression Regulation/drug effects , Humans , Protein Binding , Quantitative Trait Loci/drug effects
17.
Alcohol ; 46(8): 737-45, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22925826

ABSTRACT

Alcohol, a drug widely abused, impacts the central nervous system functioning of diverse organisms. The behavioral responses to acute alcohol exposure are remarkably similar among humans and fruit flies. In its natural environment, rich in fermentation products, the fruit fly Drosophila melanogaster encounters relatively high levels of ethanol. The effects of ethanol and its metabolites on Drosophila have been studied for decades, as a model for adaptive evolution. Although extensive work has been done for elucidating patterns of genetic variation, substantially less is known about the genomic regions or genes that underlie the genetic variation of this important trait. To identify regions containing genes involved in the responses to ethanol, we used a mapping population of recombinant inbred (RIL) lines to map quantitative trait loci (QTL) that affect variation in resistance and recovery from ethanol sedation in adults and ethanol resistance in larvae. We mapped fourteen QTL affecting the response to ethanol on the three chromosomes. Seven of the QTL influence the resistance to ethanol in adults, two QTL are related to ethanol-coma recovery in adults and five affect the survival to ethanol in larvae. Most of the QTL were trait specific, suggesting that overlapping but generally unique genetic architectures underlie each trait. Each QTL explained up to 16.8% of the genetic variance among lines. Potential candidate loci contained within our QTL regions were identified and analyzed.


Subject(s)
Drosophila Proteins/genetics , Ethanol/pharmacology , Quantitative Trait Loci/genetics , Animals , Animals, Inbred Strains , Drosophila melanogaster/drug effects , Drosophila melanogaster/genetics , Female , Gene Knockdown Techniques/methods , Male , Quantitative Trait Loci/drug effects , Random Allocation , Recombinant Proteins/genetics
18.
PLoS One ; 7(4): e34745, 2012.
Article in English | MEDLINE | ID: mdl-22496853

ABSTRACT

BACKGROUND: Aerobic organisms are susceptible to damage by reactive oxygen species. Oxidative stress resistance is a quantitative trait with population variation attributable to the interplay between genetic and environmental factors. Drosophila melanogaster provides an ideal system to study the genetics of variation for resistance to oxidative stress. METHODS AND FINDINGS: We used 167 wild-derived inbred lines of the Drosophila Genetic Reference Panel for a genome-wide association study of acute oxidative stress resistance to two oxidizing agents, paraquat and menadione sodium bisulfite. We found significant genetic variation for both stressors. Single nucleotide polymorphisms (SNPs) associated with variation in oxidative stress resistance were often sex-specific and agent-dependent, with a small subset common for both sexes or treatments. Associated SNPs had moderately large effects, with an inverse relationship between effect size and allele frequency. Linear models with up to 12 SNPs explained 67-79% and 56-66% of the phenotypic variance for resistance to paraquat and menadione sodium bisulfite, respectively. Many genes implicated were novel with no known role in oxidative stress resistance. Bioinformatics analyses revealed a cellular network comprising DNA metabolism and neuronal development, consistent with targets of oxidative stress-inducing agents. We confirmed associations of seven candidate genes associated with natural variation in oxidative stress resistance through mutational analysis. CONCLUSIONS: We identified novel candidate genes associated with variation in resistance to oxidative stress that have context-dependent effects. These results form the basis for future translational studies to identify oxidative stress susceptibility/resistance genes that are evolutionary conserved and might play a role in human disease.


Subject(s)
Drosophila melanogaster/genetics , Genome-Wide Association Study , Oxidative Stress/genetics , Animals , DNA/metabolism , Drosophila melanogaster/drug effects , Female , Herbicides/toxicity , Male , Neurogenesis/drug effects , Neurogenesis/genetics , Paraquat/toxicity , Polymorphism, Single Nucleotide , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , Vitamin K 3/adverse effects , Vitamins/adverse effects
19.
PLoS One ; 6(10): e26586, 2011.
Article in English | MEDLINE | ID: mdl-22066001

ABSTRACT

The hippocampus is critical for a wide range of emotional and cognitive behaviors. Here, we performed the first genome-wide search for genes influencing hippocampal oscillations. We measured local field potentials (LFPs) using 64-channel multi-electrode arrays in acute hippocampal slices of 29 BXD recombinant inbred mouse strains. Spontaneous activity and carbachol-induced fast network oscillations were analyzed with spectral and cross-correlation methods and the resulting traits were used for mapping quantitative trait loci (QTLs), i.e., regions on the genome that may influence hippocampal function. Using genome-wide hippocampal gene expression data, we narrowed the QTLs to eight candidate genes, including Plcb1, a phospholipase that is known to influence hippocampal oscillations. We also identified two genes coding for calcium channels, Cacna1b and Cacna1e, which mediate presynaptic transmitter release and have not been shown to regulate hippocampal network activity previously. Furthermore, we showed that the amplitude of the hippocampal oscillations is genetically correlated with hippocampal volume and several measures of novel environment exploration.


Subject(s)
Genetic Association Studies , Hippocampus/physiology , Action Potentials/drug effects , Action Potentials/genetics , Animals , Carbachol/pharmacology , Cluster Analysis , Electrodes , Gene Expression Regulation/drug effects , Hippocampus/drug effects , In Vitro Techniques , Inheritance Patterns/drug effects , Inheritance Patterns/genetics , Locomotion/drug effects , Locomotion/genetics , Mice , Mice, Inbred Strains , Nerve Net/drug effects , Nerve Net/physiology , Organ Size/drug effects , Organ Size/genetics , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , Quantitative Trait, Heritable
20.
Pharmacogenet Genomics ; 20(9): 553-64, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20657349

ABSTRACT

OBJECTIVE: Inbred long-sleep and short-sleep mice (ILS and ISS) were selectively bred for differential sensitivity to the sedative effects of ethanol. Lines of mice derived from these progenitors have been used to identify several quantitative trait loci (QTLs) mediating loss of the righting reflex due to ethanol (LORE). This study investigated the metabotropic glutamate receptor subtype 5 (mGluR5) as a candidate gene underlying Lore7, a QTL mediating differential LORE sensitivity. METHODS: We used knockout mice, a quantitative complementation test, pharmacological antagonism of mGluR5, real-time quantitative PCR, radioligand binding, DNA sequencing, and bioinformatics to examine the role of mGluR5 in ethanol-induced sedation. RESULTS: mGluR5 knockout mice had a significantly longer LORE duration than wildtype controls. Administration of the mGluR5 antagonist 2-methyl-6-(phenylethyl)-pyridine (MPEP) had differential effects on LORE in ILS and ISS mice. A quantitative complementation test also supported mGluR5 mediating LORE. Two intronic single-nucleotide polymorphisms in mGluR5 were highly correlated with LORE in recombinant inbred mice derived from a cross between ILS and ISS (LXS RIs). Differences in mGluR5 mRNA level and receptor density were observed between ILS and ISS in distinct brain regions. Finally, data from WebQTL showed that mGluR5 expression was highly correlated with several LORE phenotypes in the LXS RIs. CONCLUSION: Altogether, this data provides convincing evidence that mGluR5 mediates differential sensitivity to the sedative effects of ethanol. Studies from the human literature have also identified mGluR5 as a potential candidate gene for ethanol sensitivity.


Subject(s)
Ethanol/pharmacology , Hypnotics and Sedatives/pharmacology , Receptors, Metabotropic Glutamate/metabolism , Animals , Female , Genetic Complementation Test , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mice , Polymerase Chain Reaction , Polymorphism, Single Nucleotide/genetics , Pyridines/pharmacology , Quantitative Trait Loci/drug effects , Quantitative Trait Loci/genetics , Radioligand Assay , Receptor, Metabotropic Glutamate 5 , Receptors, Metabotropic Glutamate/genetics , Reflex/drug effects , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...